Azcuris Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
8
- Latest Deal Type
-
Series B
- (In Progress)
- Latest Deal Amount
-
$3.36M
- Investors
-
9
Azcuris General Information
Description
Developer of small molecular treatment systems designed for patients suffering from allergic diseases. The company creates low-molecular-weight drugs based on efficacy at the molecular and cellular levels for patients suffering from atopic diseases, enabling patients to find medical systems to treat diseases.
Contact Information
Website
www.azcuris.comCorporate Office
- 2511 Sejongro, Jochiwoneup
- 34-dong, 402-ho, Seochang-ri, Korea University Sejong Campus
- Sejong, 34402
- South Korea
Corporate Office
- 2511 Sejongro, Jochiwoneup
- 34-dong, 402-ho, Seochang-ri, Korea University Sejong Campus
- Sejong, 34402
- South Korea
Azcuris Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Later Stage VC (Series B) | 30-Apr-2026 | $3.36M | In Progress | Pre-Clinical Trials | ||
| 5. Accelerator/Incubator | Completed | Pre-Clinical Trials | ||||
| 4. Early Stage VC | 01-Jun-2021 | Completed | Pre-Clinical Trials | |||
| 3. Early Stage VC (Series A) | 01-Jul-2020 | Completed | Startup | |||
| 2. Accelerator/Incubator | 01-Nov-2018 | Completed | Startup | |||
| 1. Seed Round | 01-Nov-2018 | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Azcuris Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Azcuris Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Azcuris Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| JX Partners | Venture Capital | Minority | ||
| Wells Investment | Growth/Expansion | Minority | ||
| Korea University Holdings | Accelerator/Incubator | Minority | ||
| Tech Incubator Program for Startup | Accelerator/Incubator | Minority | ||
| Atinum Investment | Venture Capital | Minority |
Azcuris FAQs
-
When was Azcuris founded?
Azcuris was founded in 2018.
-
Where is Azcuris headquartered?
Azcuris is headquartered in Sejong, South Korea.
-
What is the size of Azcuris?
Azcuris has 8 total employees.
-
What industry is Azcuris in?
Azcuris’s primary industry is Drug Discovery.
-
Is Azcuris a private or public company?
Azcuris is a Private company.
-
What is the current valuation of Azcuris?
The current valuation of Azcuris is .
-
What is Azcuris’s current revenue?
The current revenue for Azcuris is .
-
How much funding has Azcuris raised over time?
Azcuris has raised $4.2M.
-
Who are Azcuris’s investors?
JX Partners, Wells Investment, Korea University Holdings, Tech Incubator Program for Startup, and Atinum Investment are 5 of 9 investors who have invested in Azcuris.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
